Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1861 AL 1875

Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6-OHDA-lesioned rats

Papathanou M, Rose S, McCreary A, Jenner P.

Eur J Neurosci. 2011 Jun;33(12):2247-54. doi: 10.1111/j.1460-9568.2011.07704.x. Epub 2011 May 25.

Impulse control disorders and dopamine dysregulation in Parkinson's disease: a broader conceptual framework

Okai D, Samuel M, Askey-Jones S, David AS, Brown RG.

Eur J Neurol. 2011 Dec;18(12):1379-83. doi: 10.1111/j.1468-1331.2011.03432.x. Epub 2011 May 25.

Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies

Knaryan VH, Samantaray S, Le Gal C, Ray SK, Banik NL.

J Neurochem. 2011 Aug;118(3):326-38. doi: 10.1111/j.1471-4159.2011.07320.x. Epub 2011 Jun 17.

Treatment of motor fluctuations in Parkinson's disease

Korczyn AD.

J Neural Transm (Vienna). 2011 Jun;118(6):905-6. doi: 10.1007/s00702-011-0661-2.

Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy

Spagnolo F, Ceppi D, Cardamone R, Falautano M, Martinelli V, Comi G, Perani D, Volonté MA.

Mov Disord. 2011 Sep;26(11):2131-2. doi: 10.1002/mds.23768. Epub 2011 May 25.

Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond

Shachar T, Lo Bianco C, Recchia A, Wiessner C, Raas-Rothschild A, Futerman AH.

Mov Disord. 2011 Aug 1;26(9):1593-604. doi: 10.1002/mds.23774. Epub 2011 May 26.

Aged monkeys as a partial model for Parkinson's disease

Hurley PJ, Elsworth JD, Whittaker MC, Roth RH, Redmond DE Jr.

Pharmacol Biochem Behav. 2011 Sep;99(3):324-32. doi: 10.1016/j.pbb.2011.05.007. Epub 2011 May 18.

β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease

Richardson JR, Roy A, Shalat SL, Buckley B, Winnik B, Gearing M, Levey AI, Factor SA, O'Suilleabhain P, German DC.

Neurotoxicology. 2011 Oct;32(5):640-5. doi: 10.1016/j.neuro.2011.04.002. Epub 2011 May 17.

The importance of non-motor disturbances to quality of life in Parkinson's disease

Martinez-Martin P.

J Neurol Sci. 2011 Nov 15;310(1-2):12-6. doi: 10.1016/j.jns.2011.05.006. Epub 2011 May 31.

Evaluation of doctor/patient satisfaction with the use of the Parkinson's Disease Dementia-Short-Screen (PDD-SS): a screening test for dementia in Parkinson's disease (DIFFUSION study)

Kulisevsky J, Pagonabarraga J, Llebaria G, Hernández B, Arranz J; Grupo de Investigadores del estudio DIFUSION.

Neurologia. 2011 Oct;26(8):461-7. doi: 10.1016/j.nrl.2011.03.013. Epub 2011 May 28.

The placebo response: how words and rituals change the patient's brain

Benedetti F, Amanzio M.

Patient Educ Couns. 2011 Sep;84(3):413-9. doi: 10.1016/j.pec.2011.04.034. Epub 2011 May 28.

Omega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection

Zhang W, Li P, Hu X, Zhang F, Chen J, Gao Y.

Front Biosci (Landmark Ed). 2011 Jun 1;16(7):2653-70. doi: 10.2741/3878.

Neuroinflammation and cell therapy for Parkinson's disease

Li F, Zhu S, Wu C, Yan C, Liu Y, Shugan L.

Front Biosci (Schol Ed). 2011 Jun 1;3(4):1407-20. doi: 10.2741/232.

Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential

Noelker C, Hampel H, Dodel R.

Mol Diagn Ther. 2011 Apr 1;15(2):83-102. doi: 10.1007/BF03256398.

Protein aggregate spreading in neurodegenerative diseases: problems and perspectives

Lee SJ, Lim HS, Masliah E, Lee HJ.

Neurosci Res. 2011 Aug;70(4):339-48. doi: 10.1016/j.neures.2011.05.008. Epub 2011 May 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias